Clinical Trial Update: Quality of Life in Diarrhea-predominant Irritable Bowel Syndrome Taking GABA [NA]

View source ↗

Summary

A completed clinical trial evaluated the impact of GABA (gamma-aminobutyric acid) on quality of life in individuals with diarrhea-predominant irritable bowel sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• GABA (gamma-aminobutyric acid)

Snippet

Sponsor: University of Pisa | Conditions: Diarrhoea Predominant Irritable Bowel Syndrome | NA | Status: COMPLETED